Key Dates

Related Announcements

PAR-20-043 - Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the Expiration Date for PAR-20-043, "Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)".

The correct Expiration date is September 26, 2022.

The following sections of PAR-20-043 are corrected with this Notice:

Part 1. Overview Information, Key Dates

Open Date (Earliest Submission Date)

December 25, 2019

Letter of Intent Due Date(s)

Not applicable

Application Due Date(s)

Standard dates apply.

All applicationsare due by 5:00 PM local time of applicant organization. Alltypes of non-AIDS applicationsallowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

AIDS Application Due Date(s)

Not applicable

Scientific Merit Review

Standard dates apply

Advisory Council Review

Standard dates apply

Earliest Start Date

Standard dates apply

Expiration Date (currently reads):

September 26, 2021

Expiration Date (modified to read in italics):

September 26, 2022

All other aspects of PAR-20-043 remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Office of Cancer Centers
National Cancer Institute (NCI)
Telephone: 240-276-5600
Email:[email protected]

Peer Review Contact(s)

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email:[email protected]

Financial/Grants Management Contact(s)

Office of Grants Administration
National Cancer Institute (NCI)
Telephone: 240-276-6277